USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plantNatco Pharma's Telangana plant violated cleanliness and sterilisation standards at Kothur Village facility per USFDA. The warning letter me...
21 Apr, 2024, 11.09 AM IST
Natco Pharma gets warning letter from USFDA for Telangana plantNatco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came ...
09 Apr, 2024, 11.41 AM IST
ESR bullish on India opportunity, in talks to acquire 8 warehousing projectsNew additions will mostly be greenfield land acquisitions besides around 6 million sq ft of projects. The latter will get operational by th...
16 Apr, 2021, 11.49 AM IST
Singapore’s GIC in pact with ESR for $750 million India logistics realty joint ventureThe joint venture will develop and own institutional-grade, state-of-the-art industrial and logistics facilities as well as acquire core as...
22 Dec, 2020, 12.26 PM IST
Stocks in the news: IndusInd Bank, Adani Ports, Mindtree, Ambuja Cements and Union BankIRB Infrastructure said its board has approved raising up to Rs 2,500 crore to fund ongoing and planned capex.
27 Apr, 2020, 07.32 AM IST
Natco Pharma gets EIR from USFDA for Telangana facilityThe United States Food and Drug Administration (USFDA) had conducted pre-approval inspection at the company's drug formulations facility in...
25 Apr, 2020, 01.49 PM IST
USFDA issues 6 observations to Natco Pharma's API facility near HyderabadThe United States Food and Drug Administration (USFDA) conducted inspection at Kothur facility between August 5-9, 2019.
12 Aug, 2019, 10.42 AM IST
USFDA issues 9 observations to Natco Pharma's Kothur facility"At the end of the inspection, the facility received 9 observations, with no repeat observations and mostly procedural in nature," Natco Ph...
06 Jun, 2019, 01.17 PM IST
The curious case of USFDA observations and skyrocketing stock pricesUS FDA investigation and observations have material impact on stock prices.
05 Mar, 2018, 12.37 PM IST
USFDA makes 6 observations at Natco Pharma's Kothur facilityNatco Pharma said it will provide due justifications and corrective action plan within next 15 working days to the address the USFDA observ...
25 Jan, 2017, 11.49 AM IST
Natco Pharma gets EIR from USFDA for Kothur facilityKothur facility predominantly caters to regulated international markets. EIR is given after the completion of the inspection by the USFDA.
16 Aug, 2016, 01.02 PM IST
Natco Pharma's partner MylanInc gets USFDA nod for cancer drugThe company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).
03 Jun, 2016, 02.52 PM IST
Natco Pharma stock plunges 13% on USFDA observationsShares of Natco Pharma plummeted 13 per cent today after the company received 483 observations from the USFDA after inspection of its two f...
28 Mar, 2016, 05.47 PM IST
Natco Pharma plunges as USFDA issues form 483 to the companyReacting to the development, the stock slumped 10.94 per cent to hit a low of Rs 417.10 on the BSE. The stock has plunged 26 per cent in th...
28 Mar, 2016, 04.28 PM IST
USFDA observations on 2 units not to impact products: Natco"The company has received 483 observations for both facilities and believes them to be of minor in nature," a statement said.
27 Mar, 2016, 06.43 PM IST
Johnson & Johnson marks Rs 650 crore more for TelanganaJ&J is looking at investing another $100 million to more than double its annual production capacity at its upcoming India's largest facilit...
02 Sep, 2015, 10.09 AM IST
Johnson and Johnson to set up Rs 400-crore plant near Hyderabad in TelanganaThe plant design will incorporate many innovative elements to ensure energy efficiency, water consumption patterns and waste management in ...
18 Sep, 2014, 07.57 PM IST